Reviewing of term sheet for licensing technology for Aptimmune Biologics

Collyer Law advised Aptimmune Biologics, Inc, a US based company which specializes in developing revolutionary mucosal vaccines, made with Barricade (TM) Formulation Technology, in connection with reviewing of term sheet for licensing technology.

Featured Posts
Recent Posts
Archive
Search By Tags
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

© Collyer Law LLC, 2015-20. All Rights Reserved.
Collyer Law LLC (UEN 201536126Z) is a limited liability law corporation licensed and regulated by the Legal Services Regulatory Authority.